Clari Vest Asset Management LLC Myriad Genetics Inc Transaction History

Clari Vest Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$22.08 - $47.08 $1.88 Million - $4.01 Million	-85,180 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$22.67 - $35.0 $13,602 - $21,000	-600 Reduced 0.7%	85,180 $2.37 Million
Q1 2019 May 13, 2019	SELL	$26.93 - $34.7 $112,944 - $145,531	-4,194 Reduced 4.66%	85,780 $2.85 Million
Q4 2018 Feb 05, 2019	BUY	$27.23 - $45.56 $644,997 - $1.08 Million	23,687 Added 35.73%	89,974 $2.62 Million
Q3 2018 Nov 07, 2018	BUY	$37.57 - $50.34 $1.02 Million - $1.37 Million	27,176 Added 69.48%	66,287 $3.05 Million
Q2 2018 Aug 10, 2018	BUY	$27.75 - $40.17 $1.08 Million - $1.57 Million	39,092 Added 205747.38%	39,111 $1.46 Million
Q4 2017 Feb 13, 2018	BUY	$28.45 - $37.14 $540 - $705	19	19 $1,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.